Page last updated: 2024-10-25

deferoxamine and Obstructive Lung Diseases

deferoxamine has been researched along with Obstructive Lung Diseases in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez-Villaron, L1
PĂ©rez-Arellano, JL1
de Castro, S1
Factor, JM1
Pottipati, SR1
Rappoport, I1
Rosner, IK1
Lesser, ML1
Giardina, PJ1

Other Studies

2 other studies available for deferoxamine and Obstructive Lung Diseases

ArticleYear
Urinary iron excretion in patients with chronic obstructive airways disease (COAD).
    Annals of clinical biochemistry, 1995, Volume: 32 ( Pt 4)

    Topics: Aged; Aged, 80 and over; Deferoxamine; Female; Ferritins; Humans; Iron; Lung Diseases, Obstructive;

1995
Pulmonary function abnormalities in thalassemia major and the role of iron overload.
    American journal of respiratory and critical care medicine, 1994, Volume: 149, Issue:6

    Topics: Adolescent; Adult; Age Factors; beta-Thalassemia; Blood Gas Analysis; Body Burden; Child; Deferoxami

1994